Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research note issued to investors on Tuesday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $7.00 price target on shares of Aethlon Medical in a research note on Friday, November 15th.

Aethlon Medical Stock Down 3.3 %

NASDAQ AEMD opened at $0.38 on Tuesday. The company has a market capitalization of $5.27 million, a price-to-earnings ratio of -0.13 and a beta of 1.79. Aethlon Medical has a twelve month low of $0.24 and a twelve month high of $2.35. The stock has a fifty day simple moving average of $0.40 and a 200 day simple moving average of $0.42.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.